Abstract
The kinetics of growth of two virulent strains of mycobacteria (M. tuberculosis Erdman and M. tuberculosis H37Rv) and two attenuated strains (M. tuberculosis H37Ra and M. bovis Bacillus Calmette-Guerin [BCG]) were studied in the lungs, livers, spleens, and kidneys of severe combined immunodeficient (SCID) mice and of their coisogenic CB- 17 immunocompetent counterparts. It was found, in keeping with the findings of earlier investigators (Pierce, C. H., R. J. Dubos, and W. B. Schaefer. 1953. J. Exp. Med. 97:189.), that in immunocompetent mice, virulent organisms grew progressively only in the lungs, whereas the growth of attenuated organisms was controlled in all organs. In SCID mice, in contrast, virulent mycobacteria grew rapidly and progressively in all organs, as did BCG, although at a slower rate. However, H37Ra failed to grow progressively in any organs of SCID mice, unless the mice were treated with hydrocortisone. In fact, hydrocortisone treatment enabled virulent, as well as attenuated, organisms to grow strikingly more rapidly in all organs of SCID mice and in all organs of CB-17 mice. A histological study showed that in SCID mice, multiplication of mycobacteria in the liver occurs in the cytoplasm of macrophages in granulomas and presumably in macrophages in other organs. It is suggested, therefore, that the macrophages of SCID mice possess a glucocorticoid-sensitive mycobacterial mechanism that prevents virulent and avirulent mycobacteria from expressing their true minimal doubling times. In the absence of this mechanism in the lungs of hydrocortisone-treated SCID mice, the doubling times of Erdman, H37Rv, BCG, and H37Ra were 17.7, 17.4, 44.6, and 98.6 h, respectively. The possible importance of a rapid multiplication rate for mycobacterial virulence is discussed.
Full Text
The Full Text of this article is available as a PDF (2.4 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bloom B. R., Jacobs W. R., Jr New strategies for leprosy and tuberculosis and for development of bacillus Calmette-Guérin into a multivaccine vehicle. Ann N Y Acad Sci. 1989;569:155–173. doi: 10.1111/j.1749-6632.1989.tb27366.x. [DOI] [PubMed] [Google Scholar]
- Centers for Disease Control (CDC) Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep. 1991 Aug 30;40(34):585–591. [PubMed] [Google Scholar]
- Centers for Disease Control (CDC) Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR Morb Mortal Wkly Rep. 1989 Apr 14;38(14):236-8, 243-50. [PubMed] [Google Scholar]
- Centers for Disease Control (CDC) Tuberculosis outbreak among persons in a residential facility for HIV-infected persons--San Francisco. MMWR Morb Mortal Wkly Rep. 1991 Sep 27;40(38):649–652. [PubMed] [Google Scholar]
- Harmsen A. G., Stankiewicz M. Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med. 1990 Sep 1;172(3):937–945. doi: 10.1084/jem.172.3.937. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Izzo A. A., North R. J. Evidence for an alpha/beta T cell-independent mechanism of resistance to mycobacteria. Bacillus-Calmette-Guerin causes progressive infection in severe combined immunodeficient mice, but not in nude mice or in mice depleted of CD4+ and CD8+ T cells. J Exp Med. 1992 Aug 1;176(2):581–586. doi: 10.1084/jem.176.2.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kaufmann S. H. Vaccines against tuberculosis: the impact of modern biotechnology. Scand J Infect Dis Suppl. 1990;76:54–59. [PubMed] [Google Scholar]
- LARSON C. L., WICHT W. C. Studies of resistance to experimental tuberculosis in mice vaccinated with living attenuated tubercle bacilli and challenged with virulent organisms. Am Rev Respir Dis. 1962 Jun;85:833–846. doi: 10.1164/arrd.1962.85.6.833. [DOI] [PubMed] [Google Scholar]
- LECHTMAN M. D., BARTHOLOMEW J. W., PHILLIPS A., RUSSO M. RAPID METHODS OF STAINING BACTERIAL SPORES AT ROOM TEMPERATURE. J Bacteriol. 1965 Mar;89:848–854. doi: 10.1128/jb.89.3.848-854.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lefford M. J. Induction and expression of immunity after BCG immunization. Infect Immun. 1977 Dec;18(3):646–653. doi: 10.1128/iai.18.3.646-653.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leveton C., Barnass S., Champion B., Lucas S., De Souza B., Nicol M., Banerjee D., Rook G. T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis. Infect Immun. 1989 Feb;57(2):390–395. doi: 10.1128/iai.57.2.390-395.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Masur H., Murray H. W., Jones T. C. Effect of hydrocortisone on macrophage response to lymphokine. Infect Immun. 1982 Feb;35(2):709–714. doi: 10.1128/iai.35.2.709-714.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Orme I. M. Evidence for a biphasic memory T-cell response to high dose BCG vaccination in mice. Tubercle. 1988 Jun;69(2):125–131. doi: 10.1016/0041-3879(88)90075-x. [DOI] [PubMed] [Google Scholar]
- PIERCE C. H., DUBOS R. J., SCHAEFER W. B. Multiplication and survival of tubercle bacilli in the organs of mice. J Exp Med. 1953 Feb 1;97(2):189–206. doi: 10.1084/jem.97.2.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pedrazzini T., Hug K., Louis J. A. Importance of L3T4+ and Lyt-2+ cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette-Guérin in mice. Assessment by elimination of T cell subsets in vivo. J Immunol. 1987 Sep 15;139(6):2032–2037. [PubMed] [Google Scholar]
- Schaffner A. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Clin Invest. 1985 Nov;76(5):1755–1764. doi: 10.1172/JCI112166. [DOI] [PMC free article] [PubMed] [Google Scholar]